Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Conflict of interest
  • Funding support
  • Supplemental material
  • Footnotes
  • References
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research LetterImmunologyInflammation Open Access | 10.1172/JCI201075

Sinus mast cell accumulation and persistence suggest a unique endotype in toxin exposure–associated chronic rhinosinusitis

Xinyu Wang,1,2 Yung-An Huang,1,2 Anshika Sethi,1,2 Christopher Yue,1,2 Sydney Brack,1,2 Aiswarya Chattuparambil Binoy,1,2 Lauren Crowther,2 Carol Yan,1,3 Adam Deconde,3 Anton Kushnaryov,1 Andrew Vahabzadeh-Hagh,1,3 Jacob Husseman,1,3 Maia Little,1,2 Allyssa Strohm,1,2 Lily Jih,1 Jonathan J. Lyons,1,2 David H. Broide,2 and Taylor A. Doherty1,2

¹VA San Diego Healthcare System, La Jolla, California, USA.

²Division of Allergy & Immunology and

3Department of Otolaryngology–Head and Neck Surgery, UCSD, La Jolla, California, USA.

Address correspondence to: Taylor A. Doherty, UCSD, 9500 Gilman Drive, La Jolla, California 92093-0635, USA. Phone: 858.822.7563; Email: tdoherty@health.ucsd.edu.

Find articles by Wang, X. in: PubMed | Google Scholar

¹VA San Diego Healthcare System, La Jolla, California, USA.

²Division of Allergy & Immunology and

3Department of Otolaryngology–Head and Neck Surgery, UCSD, La Jolla, California, USA.

Address correspondence to: Taylor A. Doherty, UCSD, 9500 Gilman Drive, La Jolla, California 92093-0635, USA. Phone: 858.822.7563; Email: tdoherty@health.ucsd.edu.

Find articles by Huang, Y. in: PubMed | Google Scholar

¹VA San Diego Healthcare System, La Jolla, California, USA.

²Division of Allergy & Immunology and

3Department of Otolaryngology–Head and Neck Surgery, UCSD, La Jolla, California, USA.

Address correspondence to: Taylor A. Doherty, UCSD, 9500 Gilman Drive, La Jolla, California 92093-0635, USA. Phone: 858.822.7563; Email: tdoherty@health.ucsd.edu.

Find articles by Sethi, A. in: PubMed | Google Scholar

¹VA San Diego Healthcare System, La Jolla, California, USA.

²Division of Allergy & Immunology and

3Department of Otolaryngology–Head and Neck Surgery, UCSD, La Jolla, California, USA.

Address correspondence to: Taylor A. Doherty, UCSD, 9500 Gilman Drive, La Jolla, California 92093-0635, USA. Phone: 858.822.7563; Email: tdoherty@health.ucsd.edu.

Find articles by Yue, C. in: PubMed | Google Scholar

¹VA San Diego Healthcare System, La Jolla, California, USA.

²Division of Allergy & Immunology and

3Department of Otolaryngology–Head and Neck Surgery, UCSD, La Jolla, California, USA.

Address correspondence to: Taylor A. Doherty, UCSD, 9500 Gilman Drive, La Jolla, California 92093-0635, USA. Phone: 858.822.7563; Email: tdoherty@health.ucsd.edu.

Find articles by Brack, S. in: PubMed | Google Scholar

¹VA San Diego Healthcare System, La Jolla, California, USA.

²Division of Allergy & Immunology and

3Department of Otolaryngology–Head and Neck Surgery, UCSD, La Jolla, California, USA.

Address correspondence to: Taylor A. Doherty, UCSD, 9500 Gilman Drive, La Jolla, California 92093-0635, USA. Phone: 858.822.7563; Email: tdoherty@health.ucsd.edu.

Find articles by Chattuparambil Binoy, A. in: PubMed | Google Scholar

¹VA San Diego Healthcare System, La Jolla, California, USA.

²Division of Allergy & Immunology and

3Department of Otolaryngology–Head and Neck Surgery, UCSD, La Jolla, California, USA.

Address correspondence to: Taylor A. Doherty, UCSD, 9500 Gilman Drive, La Jolla, California 92093-0635, USA. Phone: 858.822.7563; Email: tdoherty@health.ucsd.edu.

Find articles by Crowther, L. in: PubMed | Google Scholar

¹VA San Diego Healthcare System, La Jolla, California, USA.

²Division of Allergy & Immunology and

3Department of Otolaryngology–Head and Neck Surgery, UCSD, La Jolla, California, USA.

Address correspondence to: Taylor A. Doherty, UCSD, 9500 Gilman Drive, La Jolla, California 92093-0635, USA. Phone: 858.822.7563; Email: tdoherty@health.ucsd.edu.

Find articles by Yan, C. in: PubMed | Google Scholar

¹VA San Diego Healthcare System, La Jolla, California, USA.

²Division of Allergy & Immunology and

3Department of Otolaryngology–Head and Neck Surgery, UCSD, La Jolla, California, USA.

Address correspondence to: Taylor A. Doherty, UCSD, 9500 Gilman Drive, La Jolla, California 92093-0635, USA. Phone: 858.822.7563; Email: tdoherty@health.ucsd.edu.

Find articles by Deconde, A. in: PubMed | Google Scholar

¹VA San Diego Healthcare System, La Jolla, California, USA.

²Division of Allergy & Immunology and

3Department of Otolaryngology–Head and Neck Surgery, UCSD, La Jolla, California, USA.

Address correspondence to: Taylor A. Doherty, UCSD, 9500 Gilman Drive, La Jolla, California 92093-0635, USA. Phone: 858.822.7563; Email: tdoherty@health.ucsd.edu.

Find articles by Kushnaryov, A. in: PubMed | Google Scholar

¹VA San Diego Healthcare System, La Jolla, California, USA.

²Division of Allergy & Immunology and

3Department of Otolaryngology–Head and Neck Surgery, UCSD, La Jolla, California, USA.

Address correspondence to: Taylor A. Doherty, UCSD, 9500 Gilman Drive, La Jolla, California 92093-0635, USA. Phone: 858.822.7563; Email: tdoherty@health.ucsd.edu.

Find articles by Vahabzadeh-Hagh, A. in: PubMed | Google Scholar

¹VA San Diego Healthcare System, La Jolla, California, USA.

²Division of Allergy & Immunology and

3Department of Otolaryngology–Head and Neck Surgery, UCSD, La Jolla, California, USA.

Address correspondence to: Taylor A. Doherty, UCSD, 9500 Gilman Drive, La Jolla, California 92093-0635, USA. Phone: 858.822.7563; Email: tdoherty@health.ucsd.edu.

Find articles by Husseman, J. in: PubMed | Google Scholar

¹VA San Diego Healthcare System, La Jolla, California, USA.

²Division of Allergy & Immunology and

3Department of Otolaryngology–Head and Neck Surgery, UCSD, La Jolla, California, USA.

Address correspondence to: Taylor A. Doherty, UCSD, 9500 Gilman Drive, La Jolla, California 92093-0635, USA. Phone: 858.822.7563; Email: tdoherty@health.ucsd.edu.

Find articles by Little, M. in: PubMed | Google Scholar

¹VA San Diego Healthcare System, La Jolla, California, USA.

²Division of Allergy & Immunology and

3Department of Otolaryngology–Head and Neck Surgery, UCSD, La Jolla, California, USA.

Address correspondence to: Taylor A. Doherty, UCSD, 9500 Gilman Drive, La Jolla, California 92093-0635, USA. Phone: 858.822.7563; Email: tdoherty@health.ucsd.edu.

Find articles by Strohm, A. in: PubMed | Google Scholar

¹VA San Diego Healthcare System, La Jolla, California, USA.

²Division of Allergy & Immunology and

3Department of Otolaryngology–Head and Neck Surgery, UCSD, La Jolla, California, USA.

Address correspondence to: Taylor A. Doherty, UCSD, 9500 Gilman Drive, La Jolla, California 92093-0635, USA. Phone: 858.822.7563; Email: tdoherty@health.ucsd.edu.

Find articles by Jih, L. in: PubMed | Google Scholar

¹VA San Diego Healthcare System, La Jolla, California, USA.

²Division of Allergy & Immunology and

3Department of Otolaryngology–Head and Neck Surgery, UCSD, La Jolla, California, USA.

Address correspondence to: Taylor A. Doherty, UCSD, 9500 Gilman Drive, La Jolla, California 92093-0635, USA. Phone: 858.822.7563; Email: tdoherty@health.ucsd.edu.

Find articles by Lyons, J. in: PubMed | Google Scholar

¹VA San Diego Healthcare System, La Jolla, California, USA.

²Division of Allergy & Immunology and

3Department of Otolaryngology–Head and Neck Surgery, UCSD, La Jolla, California, USA.

Address correspondence to: Taylor A. Doherty, UCSD, 9500 Gilman Drive, La Jolla, California 92093-0635, USA. Phone: 858.822.7563; Email: tdoherty@health.ucsd.edu.

Find articles by Broide, D. in: PubMed | Google Scholar

¹VA San Diego Healthcare System, La Jolla, California, USA.

²Division of Allergy & Immunology and

3Department of Otolaryngology–Head and Neck Surgery, UCSD, La Jolla, California, USA.

Address correspondence to: Taylor A. Doherty, UCSD, 9500 Gilman Drive, La Jolla, California 92093-0635, USA. Phone: 858.822.7563; Email: tdoherty@health.ucsd.edu.

Find articles by Doherty, T. in: PubMed | Google Scholar |

Published February 10, 2026 - More info

Published in Volume 136, Issue 8 on April 15, 2026
J Clin Invest. 2026;136(8):e201075. https://doi.org/10.1172/JCI201075.
© 2026 Wang et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published February 10, 2026 - Version history
View PDF

To the Editor: Chronic rhinosinusitis (CRS) affects approximately 8%–10% of the general population with an economic burden of billions of dollars (1). Comorbid CRS further significantly increases the severity of asthma (2). Exposure to wildfires and military combustion burn pits leads to inhalation of multiple toxins (3). CRS is increased 3-fold among military veterans with deployment-related exposures to airborne toxins and is associated with more severe symptoms (4). Additionally, nonmilitary CRS patients, including those exposed to combustion exhaust (e.g., mechanics and drivers), require surgery 6 times more frequently for uncontrolled symptoms (5).

CRS is broadly categorized by the presence (CRSwNP) or absence (CRSsNP) of nasal polyps and endotypes based on tissue eosinophils and neutrophils. Currently, there are no FDA-approved therapies for CRSsNP. Mast cells (MCs) are an understudied immune population in CRS and are activated by allergen-IgE binding and non-IgE mechanisms such as cytokines and xenobiotics. The integrin-dependent accumulation and long-lived nature of tissue MCs may promote chronic inflammation (6). Here, we demonstrate enrichment of sinus MCs in burn pit–exposed military veterans with CRS and persistent sinonasal MC accumulation in mice exposed to environmental toxins.

We performed flow cytometry on ethmoid sinus samples obtained from patients undergoing routine sinus surgery (Figure 1, A and B, and Supplemental Figure 1, A and B; supplemental material available online with this article; https://doi.org/10.1172/JCI201075DS1). No difference in tissue eosinophils or neutrophils was observed in deployment exposure CRS samples compared with CRS without exposures. However, there was over a 2-fold increase in sinus MCs (2.829% vs. 1.227%, P = 0.0185) in exposed samples primarily from CRSsNP (Figure 1B and Supplemental Figure 1B). Smoking history trended higher in the exposure group (Supplemental Table 1), though multiple regression demonstrated that exposures were an independent predictor of sinus MCs (P = 0.0404). There were also more subjects with obstructive sleep apnea in the exposed cohort (69% vs. 10%, P = 0.0097). We observed a positive correlation between deployment duration and sinus MC burden (Supplemental Figure 1C). Tissue toluidine blue staining showed increased subepithelial MCs in exposed samples (Figure 1C), and sinus MCs were further increased in exposed patients with positive fungal allergen–specific (Alternaria) IgE (Supplemental Figure 1D). Unbiased bulk RNA-seq of exposed sinus tissue revealed upregulation of arachidonic acid metabolism and xenobiotic pathways that are critical to MC function and toxin metabolism, respectively (Figure 1D and Supplemental Figure 1E). Exposed sinuses showed increased expression of the MC-related transcripts TPSAB1 (encodes tryptase α/β1) and HDC (encodes histidine decarboxylase), as well as ITGB7 (encodes integrin β7), which is critical to MC tissue trafficking (Figure 1D). A mucosal mast cell (MCT) signature suggested MCTs as the prominent MC subset (Supplemental Figure 1F).

Sinus MCs are enriched in burn pit–exposed military veterans with CRS and iFigure 1

Sinus MCs are enriched in burn pit–exposed military veterans with CRS and in mice exposed to environmental combustion-related compounds. (A) Sinus MC gating from control and toxin-exposed tissue. (B) Granulocyte percentage of CD45+ leukocytes for individual control (n = 10) and exposed (n = 13) subjects. Data are presented as mean ± SEM; Student’s t test. (C) Tissue toluidine blue staining. Red arrows indicate MCs. Scale bars = 60 μm; original magnification, ×40. (D) Sinus tissue bulk RNA-seq from control (n = 10) and exposed (n = 10) subjects. GSEA of enriched pathways and violin plots of key MC transcripts with adjusted P values shown. (E) H&E- or toluidine blue–stained sections of mouse sinonasal respiratory epithelium after 4 weeks of exposure to ALT, CPC, or a combination. Red arrows indicate MCs. Scale bars = 20 μm. (F) Total and Integrin B7+ MCs in mouse sinonasal tissue over 8 weeks. Data are presented as mean ± SEM for n = 4 mice per time point. Mixed-effects model (restricted maximum likelihood) and Tukey’s multiple-comparison test at indicated time points (*P < 0.05, **P < 0.01). (G) Representative flow plots of Integrin β7 and ST2 MCs.

To test the effect of combustion-related product compounds (CPCs) on sinonasal inflammation and MC accumulation in vivo, mice received intranasal particulate matter, polycyclic aromatic hydrocarbon, and dioxin, with and without the allergen Alternaria (ALT) (Figure 1, E–G). Exposure to ALT or CPCs alone induced submucosal inflammation and epithelial hyperplasia, though these changes were enhanced upon exposure to ALT with CPCs, along with increased subepithelial MCs (Figure 1E). ALT and ALT+CPC-treated mice displayed increases in sinonasal MC numbers at 2 and 4 weeks of exposure, as well as in Integrin B7+ MCs, suggesting active recruitment of MC progenitors (Figure 1, F and G). Mouse sinonasal MC identification was confirmed by FACS purification and morphologic assessment (Supplemental Figure 2, A and B). There were no significant differences in tissue neutrophils or eosinophils (Supplemental Figure 2C). In contrast to ALT-challenged mice, total and Integrin B7+ MC numbers continued to increase in ALT+CPC-challenged mice for 4 weeks without further challenges (Figure 1F). Male mice also had a more pronounced MC response to ALT+CPC challenge compared with females (Supplemental Figure 2D). This suggests that CPC potentiates allergen-driven sinonasal inflammation and leads to persistent MC accumulation.

Our study demonstrates sinus MC enrichment in veterans with CRSsNP who were previously exposed to airborne toxins during deployment. This finding was independent of smoking history and tissue eosinophils and neutrophils. We also found that coexposure to aeroallergens and toxins in mice led to persistent MC accumulation long after airway exposures. Our work suggests a novel CRS endotype related to previous toxin exposure. Future studies are needed with large CRS cohorts to investigate exposure links to gender, allergic status, and other conditions, including obstructive sleep apnea. These findings have significant clinical implications, including the potential use of MC-targeted therapies in toxin-related CRS.

Detailed methods, biological variables, statistics, study approval, author contributions, acknowledgments, and a list of differentially expressed pathways and genes are provided in the supplemental materials.

Conflict of interest

The authors have declared that no conflict of interest exists.

Funding support

This work is the result of NIH funding, in whole or in part, and is subject to the NIH Public Access Policy. Through acceptance of this federal funding, the NIH has been given a right to make the work publicly available in PubMed Central.

  • NIH grants (A171795 to TAD; A171795, AI070535, AI242236, and AI107779 to DHB; AI 007469 to XW; and AI138586 to JJL).
  • Veterans Affairs (BX005073 to TAD).
  • UCSD Stem Cell Program and California Institute for Regenerative Medicine Major Facilities grant (FA1-00607) to the Sanford Consortium for Regenerative Medicine.
Supplemental material

View Supplemental data

View Supplemental data set 1

View Supporting data values

Footnotes

Copyright: © 2026, Wang et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.

Reference information: J Clin Invest. 2026;136(8):e201075. https://doi.org/10.1172/JCI201075.

References
  1. Kato A, et al. Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches. Allergy. 2022;77(3):812–826.
    View this article via: CrossRef PubMed Google Scholar
  2. Ryu G, et al. Bidirectional association between asthma and chronic rhinosinusitis: two longitudinal follow-up studies using a national sample cohort. Sci Rep. 2020;10(1):9589.
    View this article via: CrossRef PubMed Google Scholar
  3. Masiol M, et al. Source apportionment of airborne dioxins, furans, and polycyclic aromatic hydrocarbons at a United States forward operating air base during the Iraq War. J Occup Environ Med. 2016;58(8 suppl 1):S31–S37.
    View this article via: CrossRef PubMed Google Scholar
  4. Hill CJ, et al. Burn pit exposure is associated with increased sinonasal disease. J Occup Environ Med. 2022;64(8):629–634.
    View this article via: CrossRef PubMed Google Scholar
  5. Dietz de Loos DAE, et al. Occupational exposure influences control of disease in patients with chronic rhinosinusitis. Rhinology. 2021;59(4):380–386.
    View this article via: CrossRef PubMed Google Scholar
  6. Kaltenbach L, et al. Slow integrin-dependent migration organizes networks of tissue-resident mast cells. Nat Immunol. 2023;24(6):915–924.
    View this article via: CrossRef PubMed Google Scholar
Version history
  • Version 1 (February 10, 2026): In-Press Preview
  • Version 2 (April 15, 2026): Electronic publication

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Conflict of interest
  • Funding support
  • Supplemental material
  • Footnotes
  • References
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts